{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:50:17Z","timestamp":1761058217774},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1973,9,1]],"date-time":"1973-09-01T00:00:00Z","timestamp":115689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[1973,9]]},"DOI":"10.1007\/bf01218447","type":"journal-article","created":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T13:29:14Z","timestamp":1109338154000},"page":"356-363","source":"Crossref","is-referenced-by-count":3,"title":["Clinical experience with glipizide in the treatment of mostly complicated diabetes"],"prefix":"10.1007","volume":"9","author":[{"given":"A.","family":"Masbernard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Giudicelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Massey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"200","volume":"21","author":"V. Ambrogi","year":"1971","unstructured":"Ambrogi, V., Bloch, K., Daturi, S., Griggi, P., Logemann, W., Parenti, M.A., Rabini, T., Tommasini, R.: New oral antidiabetic drugs. Arzneimittelforsch.21, 200?208 (1971).","journal-title":"Arzneimittelforsch."},{"key":"CR2","first-page":"208","volume":"21","author":"V. Ambrogi","year":"1971","unstructured":"Ambrogi, V., Bloch, K., Daturi, S., Griggi, P., Logemann, W., Mandelli, V., Parenti, A., Rabini, T., Usardi, M.M., Tommasini, R.: Pharmacological study of a new oral antidiabetic: N-(4-(?-(5-methylpyrazi-ne 2-carboxamido)-ethyl)-benzenesulfonyl)-N?-cyclohexylurea or K 4024. Arzneimittelforsch.21, 208?215 (1971)","journal-title":"Arzneimittelforsch."},{"key":"CR3","first-page":"1013","volume":"101","author":"W. Berger","year":"1971","unstructured":"Berger, W.: 88 schwere Hypoglyk\u00e4miezwischenf\u00e4lle unter der Behandlung mit Sulfonyl-Harnstoffen. Resultate einer gesamtschweizerischen Umfrage in den Jahren 1968 und 1969. Schweiz. med. Wschr.101, 1013?1022 (1971)","journal-title":"Schweiz. med. Wschr."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1055\/s-0028-1108869","volume":"95","author":"W. Berger","year":"1970","unstructured":"Berger, W., Spring, P.: Ver\u00e4nderung der Pharmakokinetik oraler Antidiabetika durch medikament\u00f6se Interferenz und Niereninsuffizienz. Dtsch. med. Wschr.95, 2525?2527 (1970)","journal-title":"Dtsch. med. Wschr."},{"key":"CR5","first-page":"251","volume":"102","author":"J. Fabre","year":"1972","unstructured":"Fabre, J.: Comment prescrire les m\u00e9dicaments en pr\u00e9sence de fonctions r\u00e9nales d\u00e9ficientes ? Tables d'adaptation posologique. Schweiz. med. Wschr.102, 251?256 (1972)","journal-title":"Schweiz. med. Wschr."},{"key":"CR6","volume-title":"Influence de fonctions r\u00e9nales d\u00e9ficientes sur le comportement de la glipizide (sulfonylur\u00e9e hypoglyc\u00e9miante) et de ses m\u00e9tabolites","author":"J. Fabre","year":"1972","unstructured":"Fabre, J., Balant, L., Zahnd, G.: Influence de fonctions r\u00e9nales d\u00e9ficientes sur le comportement de la glipizide (sulfonylur\u00e9e hypoglyc\u00e9miante) et de ses m\u00e9tabolites. Montpellier: C.-R. Soc. N\u00e9phrologie, 1972"},{"key":"CR7","unstructured":"Fuccella, L.M., Tamassia, V., Valzelli, G.: Metabolism and kinetics of the hypoglycaemic agent glipizide in man ?Comparison with glibenclamide. J. clin. Pharmacol. (In press)"},{"key":"CR8","first-page":"2829","volume":"62","author":"A.V. Greco","year":"1971","unstructured":"Greco, A.V., Fedeli, G., Chiranda, G., Lucente, M., Accietto, F., Fenici, R.: Esperienze cliniche sull'azione du un nuovo antidiabetico orale: la glydiazinamide. Minerva med.62, 2829?2839, (1971)","journal-title":"Minerva med."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01212061","volume":"7","author":"E. Haupt","year":"1971","unstructured":"Haupt, E., K\u00f6berich, W., Bemer, J.: Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. Diabetologia7, 449?460 (1971)","journal-title":"Diabetologia"},{"key":"CR10","first-page":"473","volume":"116","author":"J. Hazard","year":"1965","unstructured":"Hazard, J., Domart, A.: Deux cas d'h\u00e9mipl\u00e9gie r\u00e9v\u00e9latrice d'une hypoglyc\u00e9mie s\u00e9v\u00e8re provoqu\u00e9e par les sulfamides hypoglyc\u00e9miants Bull. Soc. M\u00e9d. Paris.116, 473?476 (1965)","journal-title":"Bull. Soc. M\u00e9d. Paris."},{"key":"CR11","first-page":"2371","volume":"41","author":"M. Lamotte","year":"1965","unstructured":"Lamotte, M., Segrestaa, J.M., Martin, E., Vilde, J.L.: Hypoglyc\u00e9mie mortelle par sulfamide hypoglyc\u00e9miant chez un patient porteur d'un ad\u00e9nome du cortex surr\u00e9nal et d'une insuffisance r\u00e9nale. Sem. H\u00f4p. Paris41, 2371?2374 (1965)","journal-title":"Sem. H\u00f4p. Paris"},{"key":"CR12","first-page":"461","volume":"116","author":"Cl. Laroche","year":"1965","unstructured":"Laroche, Cl., Nenna, A., Cremer, G., Caquet, R.: Hypoglyc\u00e9mies graves chez les diab\u00e9tiques trait\u00e9s par les sulfamides hypoglyc\u00e9miants. Bull. Soc. M\u00e9d. Paris116, 461?466 (1965)","journal-title":"Bull. Soc. M\u00e9d. Paris"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01219983","volume":"8","author":"A. Loubatieres","year":"1972","unstructured":"Loubatieres, A., Mariani, M.M., Ribes, G.: Pharmacological study of a new hypoglycaemic sulfonamide, glisoxepid (R.P. 22.410). Diabetologia8, 29?36 (1972)","journal-title":"Diabetologia"},{"key":"CR14","first-page":"215","volume":"21","author":"S. Marigo","year":"1971","unstructured":"Marigo, S., Del Novo, G., Bini, P.P., Sacchetti, G.: Pharmacological methods for evaluating a new hypoglycaemic agent in humans: a multiple design. Arzneimittel-Forsch.21, 215?220 (1971)","journal-title":"Arzneimittel-Forsch."},{"key":"CR15","first-page":"569","volume":"48","author":"A. Masbernard","year":"1972","unstructured":"Masbernard, A., Portal, A.: Le vrai probl\u00e8me du diab\u00e8te. Essai du gliclazide, mol\u00e9cule originale \u00e0 propri\u00e9t\u00e9s m\u00e9taboliques et vasculaires. Th\u00e9rapeutique48, 569?574 (1972)","journal-title":"Th\u00e9rapeutique"},{"key":"CR16","first-page":"97","volume":"225","author":"R. Montgolfier de","year":"1971","unstructured":"Montgolfier, R. de, Kressmann, J., Plauchu, M.: Les accidents hypoglyc\u00e9miques des sulfamides antidiab\u00e9tiques. Lyon med.225, 97?108 (1971)","journal-title":"Lyon med."},{"key":"CR17","first-page":"53","volume":"59","author":"C. Nissen-Druey","year":"1970","unstructured":"Nissen-Druey, C., Berger, W., Huber, F.: Hypoglyk\u00e4mien bei der Anwendung oraler Antidiabetika. Praxis59, 53?57 (1970)","journal-title":"Praxis"},{"key":"CR18","unstructured":"Parodi, F.A.: Pharmacological and clinical evaluation of the activity of a new oral antidiabetic, glydiazinamide (K 2024). (Unpublished report)."},{"key":"CR19","first-page":"220","volume":"21","author":"F. Pedrazzi","year":"1971","unstructured":"Pedrazzi, F., Pisani Ceretti, A., Losi, S., Bommartini, F., Artini, D., Emanueli, A.: Evaluation in hospitalized subjects of a new hypoglycaemic sulfonylurea, glydiazinamide Arzneimittel-Forsch.21, 220?225 (1971)","journal-title":"Arzneimittel-Forsch."},{"key":"CR20","volume-title":"Renal function and drug action","author":"M.M. Reidenberg","year":"1971","unstructured":"Reidenberg, M.M.: Renal function and drug action. London: W.B. Saunders Co. 1971"},{"key":"CR21","unstructured":"Schach von Wittenau, M.: Metabolism of K 2024 (glydiazinamide) in man, dog, rat and mouse. (Unpublished report)"},{"key":"CR22","first-page":"21","volume":"118","author":"J.J. Vazquez Rodriguez","year":"1970","unstructured":"Vazquez Rodriguez, J.J., Barreira Tella, P., Ortiz Vazquez, J.: Hipoglicemias por antidiabeticos orales. Rev. clin. esp.118, 21?30 (1970)","journal-title":"Rev. clin. esp."},{"key":"CR23","first-page":"158","volume":"117","author":"A. Vazquez","year":"1970","unstructured":"Vazquez, A., Moya, G.G., Ricoy, J.R.: Aspectos neurologicos de los comas hipoglicemicos de origen medico por uso de hipoglicemiantes. Rev. clin. esp.117, 158?168 (1970)","journal-title":"Rev. clin. esp."},{"key":"CR24","unstructured":"Viars, P., Seebacher, J.: Les interf\u00e9rences m\u00e9dicamenteuses. Risques th\u00e9rapeutiques et incompatibilit\u00e9s. Paris: Arnette Edit. 1971"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01218447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01218447\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01218447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T05:37:39Z","timestamp":1556602659000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01218447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1973,9]]},"references-count":24,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1973,9]]}},"alternative-id":["BF01218447"],"URL":"https:\/\/doi.org\/10.1007\/bf01218447","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[1973,9]]}}}